ATE179612T1 - Hochdosierte topische kollagenaseformen - Google Patents

Hochdosierte topische kollagenaseformen

Info

Publication number
ATE179612T1
ATE179612T1 AT92310008T AT92310008T ATE179612T1 AT E179612 T1 ATE179612 T1 AT E179612T1 AT 92310008 T AT92310008 T AT 92310008T AT 92310008 T AT92310008 T AT 92310008T AT E179612 T1 ATE179612 T1 AT E179612T1
Authority
AT
Austria
Prior art keywords
collagenase
forms
high dose
dose topical
topical
Prior art date
Application number
AT92310008T
Other languages
English (en)
Inventor
Harold Dr Stern
David Dr Yee
Original Assignee
Advance Biofactures Curacao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance Biofactures Curacao filed Critical Advance Biofactures Curacao
Application granted granted Critical
Publication of ATE179612T1 publication Critical patent/ATE179612T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
AT92310008T 1991-11-20 1992-11-02 Hochdosierte topische kollagenaseformen ATE179612T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79591591A 1991-11-20 1991-11-20
US07/963,995 US5393792A (en) 1991-11-20 1992-10-29 High dosage topical forms of collagenase

Publications (1)

Publication Number Publication Date
ATE179612T1 true ATE179612T1 (de) 1999-05-15

Family

ID=27121667

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92310008T ATE179612T1 (de) 1991-11-20 1992-11-02 Hochdosierte topische kollagenaseformen

Country Status (12)

Country Link
US (3) US5393792A (de)
EP (1) EP0543521B1 (de)
JP (1) JPH0789871A (de)
AT (1) ATE179612T1 (de)
AU (1) AU654881B2 (de)
CA (1) CA2083333C (de)
DE (1) DE69229098T2 (de)
ES (1) ES2130162T3 (de)
HU (1) HUT62802A (de)
RU (1) RU2129862C1 (de)
SI (1) SI9200334A (de)
YU (1) YU98792A (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE213955T1 (de) * 1994-12-15 2002-03-15 Advance Biofactures Curacao Verminderung des fettgewebes durch verwendung von kollagenase
US6958150B2 (en) 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
DE19503338C2 (de) * 1995-02-02 1998-07-30 Lohmann Therapie Syst Lts Arzneiform zur Abgabe von Kollagenase an Wunden und Verfahren zu ihrer Herstellung und ihre Verwendung
US5718897A (en) * 1995-06-07 1998-02-17 Trustees Of Tufts College Enhancing keratinocyte migration and proliferation
US5851522A (en) * 1995-06-07 1998-12-22 Trustees Of Tufts College Enhancing keratinocyte migration
DE19521829A1 (de) * 1995-06-16 1996-12-19 Knoll Ag Neue Verwendung von Collagenase
US6086872A (en) * 1997-03-27 2000-07-11 Advance Biofactures Of Curacao, Nv Amelioration of dupuytren's disease
AU3954199A (en) * 1998-06-03 1999-12-20 Hwa Seong Kim Adhesion / fixation / cooling remedies for burn and therapeutic method for relieving burn scar
DE19825794A1 (de) * 1998-06-10 1999-12-16 Knoll Ag Collagenase-Applikationsform
IL127209A0 (en) * 1998-11-23 1999-09-22 Bio Silk Ltd Composition and method for treatment of hypertrophic skin accumulations and their prevention
US20030198631A1 (en) * 2002-04-18 2003-10-23 Healthpoint, Ltd. Thermolysin enzymatic wound debrider
US7169405B2 (en) * 2003-08-06 2007-01-30 Warsaw Orthopedic, Inc. Methods and devices for the treatment of intervertebral discs
US20050220821A1 (en) * 2004-03-31 2005-10-06 Allergan, Inc. Pressure sore treatment
EP1773379A4 (de) * 2004-07-13 2009-07-15 Mediwound Ltd Zusammensetzungen und verfahren zur heilung von hautwunden
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
ITPD20050207A1 (it) * 2005-07-07 2007-01-08 Fidia Farmaceutici Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
CN1935262B (zh) * 2005-09-23 2010-12-29 沈阳胜宝康生物制药有限公司 红色诺卡氏菌细胞壁骨架在制备抗人乳头瘤病毒药物的用途
US20070141106A1 (en) * 2005-10-19 2007-06-21 Bonutti Peter M Drug eluting implant
US7811560B2 (en) * 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
US7879027B2 (en) * 2006-04-24 2011-02-01 Warsaw Orthopedic, Inc. Controlled release devices for fusion of osteal structures
US7771414B2 (en) * 2006-04-24 2010-08-10 Warsaw Orthopedic, Inc. Controlled release devices for therapeutic treatments of spinal discs
US8642060B2 (en) * 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for osteal growth
US8642059B2 (en) * 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for intervertebral discs
US8323642B2 (en) * 2006-12-13 2012-12-04 Depuy Mitek, Inc. Tissue fusion method using collagenase for repair of soft tissue
US10071143B1 (en) 2007-05-03 2018-09-11 The Research Foundation For The State University Of New York Methods for non-surgical treatment of carpal tunnel syndrome
US20100159564A1 (en) * 2007-11-30 2010-06-24 Dwulet Francis E Protease resistant recombinant bacterial collagenases
WO2010050980A1 (en) * 2008-10-31 2010-05-06 Laboratory Skin Care, Inc. Topical formulations comprising hydroxyapatite particles for stimulation and maintenance of collagen fibers
AU2010328269B2 (en) 2009-12-08 2014-07-10 Smith & Nephew Orthopaedics Ag Enzymatic wound debriding compositions with enhanced enzymatic activity
US10119131B2 (en) 2011-03-16 2018-11-06 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
ES2740499T3 (es) 2012-01-12 2020-02-05 Endo Global Ventures Enzima de Clostridium histolyticum
US10537293B2 (en) * 2012-02-21 2020-01-21 Canon Medical Systems Corporation X-ray CT system, image display device, and image display method
US9636385B2 (en) 2012-10-24 2017-05-02 The Research Foundation For The State University Of New York Use of collagenase to treat glaucoma
US11382958B2 (en) 2016-01-31 2022-07-12 Mediwound Ltd. Debriding composition for treating wounds
WO2017183018A1 (en) 2016-04-18 2017-10-26 Mediwound Ltd Methods of debridement of chronic wounds
CN115969318A (zh) 2017-03-01 2023-04-18 恩多风投有限公司 用于评估和治疗橘皮组织的装置和方法
MX2019011574A (es) 2017-03-28 2019-12-19 Endo Ventures Ltd Método mejorado para producir aplicaciones relacionadas con la colagenasa.
US20220362327A1 (en) * 2021-05-13 2022-11-17 Nasser Diab Compositions and methods for wound healing

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH437641A (de) * 1961-05-30 1967-06-15 Bernburg Serum Werk Veb Verfahren zur Herstellung von fettfreien Salbengrundlagen
US3392161A (en) * 1964-10-15 1968-07-09 Gen Tire & Rubber Co Gel-free halogenated polybutadiene rubber-resins
US3705083A (en) * 1966-07-08 1972-12-05 Agricultural Biolog Corp Process for producing collagenase
US3792161A (en) * 1970-05-18 1974-02-12 Research Corp Burn ointment comprising silver sulfadiazine and collagenase
US3678158A (en) * 1971-05-11 1972-07-18 Worthington Bio Chem Corp Treatment of herniated intervertebral discs of mammals
US4089333A (en) * 1972-10-28 1978-05-16 Nippi, Incorporated Method of treating a wound or burn
US3876501A (en) * 1973-05-17 1975-04-08 Baxter Laboratories Inc Binding enzymes to activated water-soluble carbohydrates
US4174389A (en) * 1977-05-13 1979-11-13 Cope Louise A Ophthalmic use of collagenase
US4338300A (en) * 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
US4485088A (en) * 1982-03-26 1984-11-27 Bio-Products, Inc. Method of treatment of fibrotic lesions by topical administration of lathyrogenic drugs
US4524065A (en) * 1983-08-04 1985-06-18 Bio-Specifics N.V. Method for the prevention and treatment of scars with enzymes
GB2150833B (en) * 1983-12-08 1987-04-15 Ceskoslovenska Akademie Ved Proteolytic wounds dressing
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
US5173295A (en) * 1990-10-05 1992-12-22 Advance Biofactures Of Curacao, N.V. Method of enhancing the regeneration of injured nerves and adhesive pharamaceutical formulation therefor

Also Published As

Publication number Publication date
US5393792A (en) 1995-02-28
SI9200334A (en) 1993-06-30
HUT62802A (en) 1993-06-28
US5514370A (en) 1996-05-07
JPH0789871A (ja) 1995-04-04
CA2083333C (en) 2000-05-30
EP0543521A2 (de) 1993-05-26
AU654881B2 (en) 1994-11-24
EP0543521B1 (de) 1999-05-06
DE69229098D1 (de) 1999-06-10
YU98792A (sh) 1995-12-04
HU9203623D0 (en) 1993-01-28
CA2083333A1 (en) 1993-05-21
AU2853592A (en) 1993-05-27
ES2130162T3 (es) 1999-07-01
DE69229098T2 (de) 1999-09-09
US5422103A (en) 1995-06-06
EP0543521A3 (en) 1993-07-28
RU2129862C1 (ru) 1999-05-10

Similar Documents

Publication Publication Date Title
ATE179612T1 (de) Hochdosierte topische kollagenaseformen
RU92004549A (ru) Высокодозированные формы коллагеназы для наружного применения
BR9303469A (pt) Conjugado de interferon,composto,processo de preparacao de um conjugado de interferon,use e composicoes farmaceuticas
ATE113650T1 (de) Ausgewählte stämme von lactobacillus enthaltende pharmazeutische zusammensetzungen.
AR092919A2 (es) Composicion farmaceutica liquida
DE69810481D1 (de) Stabilisierte antikörperformulierung
DE69214938D1 (de) Mittel zur topischen verabreichung von arzneiwirkstoffen
DE68913132D1 (de) Hirudin und Aktivator des Plasminogens enthaltende pharmazeutische wirksame Verbindung.
GR3030528T3 (en) Viscoelastic compositions of fluorinated organic compounds
IT1281188B1 (it) Composizione per prevenire e trattare infiammazioni con immunoglobulina a.
IT8423263A1 (it) Formulazioni farmaceutiche acquose di piroxicam monoidrato
ES2099021B1 (es) Composicion farmaceutica que tiene actividad analgesica.
FR2674754B1 (fr) Composition medicamenteuse micronisee.
NO932843D0 (no) Farmasoeytiske preparater
DE69434199D1 (de) Absorptionsförderer für topische pharmazeutische formulierungen
JPS5781409A (en) External plaster
NO884123D0 (no) Stabilisering av terapeutisk virksomme proteiner i farmasoeytiske preparater.
DK0800384T3 (da) Pharmaceutiske tabletformuleringer til direkte kompression
ATE106732T1 (de) Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung.
ATE126064T1 (de) Arzneizusammensetzungen zur rektalen verabreichung enthaltend gefriergetrocknetes calcitonin.
ATE33552T1 (de) Dermatologische praeparate.
IT1216233B (it) Utilizzazione della forma farmaceutica 'gel'contenente acido n (2,6 dicloro m tolil) antranilico (acido meclofenamico) impiegabile in terapia per uso topico.
IT1264428B1 (it) Composizioni farmaceutiche per il trattamento della psoriasi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee